|
Volumn 354, Issue 17, 2006, Pages 1848-1849
|
Hypertonic saline for cystic fibrosis [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMILORIDE;
AQUAPORIN;
AQUAPORIN 3;
CORTICOSTEROID;
HYPERTONIC SOLUTION;
SODIUM CHLORIDE;
STEROID;
SODIUM CHANNEL BLOCKING AGENT;
CALCIUM;
MUCIN;
APICAL MEMBRANE;
CANCER CELL CULTURE;
CELL STRAIN;
CYSTIC FIBROSIS;
HUMAN;
IN VITRO STUDY;
KIDNEY CELL;
KIDNEY EPITHELIUM;
LETTER;
LUNG ADENOCARCINOMA;
LUNG FUNCTION;
MUCOCILIARY CLEARANCE;
OSMOSIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN INDUCTION;
RESPIRATORY EPITHELIUM;
WATER PERMEABILITY;
DRUG EFFECT;
FORCED EXPIRATORY VOLUME;
INHALATIONAL DRUG ADMINISTRATION;
NOTE;
DRUG COMBINATION;
METABOLISM;
PREMEDICATION;
UPREGULATION;
MUCUS;
VISCOSITY;
ADMINISTRATION, INHALATION;
CYSTIC FIBROSIS;
FORCED EXPIRATORY VOLUME;
HUMANS;
MUCOCILIARY CLEARANCE;
SALINE SOLUTION, HYPERTONIC;
ADRENAL CORTEX HORMONES;
AMILORIDE;
AQUAPORIN 3;
DRUG THERAPY, COMBINATION;
PREMEDICATION;
SODIUM CHANNEL BLOCKERS;
UP-REGULATION;
CALCIUM;
MUCINS;
MUCUS;
VISCOSITY;
|
EID: 33646113137
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc060351 Document Type: Letter |
Times cited : (2)
|
References (4)
|